CYP17A1, which converts testosterone to estradiol, is a promising non-small lung cancer (NSCLC) susceptible candidate gene, but its polymorphisms are not associated with NSCLC development in Asian populations (21). The gene discussed is CYP17A1; the disease is non-small cell lung carcinoma.